Healthcare provider profile · identity verified

John W Holman, M.D.

Internal Medicine · GREENWOOD, SC · NPI 1922095405

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	501	175
Atorvastatin Calcium	Atorvastatin Calcium	441	160
Amlodipine Besylate	Amlodipine Besylate	429	155
Metoprolol Succinate	Metoprolol Succinate	376	138
Levothyroxine Sodium	Levothyroxine Sodium	321	111
Omeprazole	Omeprazole	272	108
Hydrochlorothiazide	Hydrochlorothiazide	213	75
Rosuvastatin Calcium	Rosuvastatin Calcium	204	83
Zolpidem Tartrate	Zolpidem Tartrate	190	45
Pantoprazole Sodium	Pantoprazole Sodium	173	68
Pravastatin Sodium	Pravastatin Sodium	171	57
Potassium Chloride	Potassium Chloride	166	64
Triumeq	Abacavir/Dolutegravir/Lamivudi	166	25
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	164	27
Famotidine	Famotidine	155	63
Lisinopril	Lisinopril	142	55
Furosemide	Furosemide	134	51
Eliquis	Apixaban	128	34
Escitalopram Oxalate	Escitalopram Oxalate	120	40
Albuterol Sulfate Hfa	Albuterol Sulfate	116	32
Chlorthalidone	Chlorthalidone	115	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	107	35
Finasteride	Finasteride	105	42
Clopidogrel	Clopidogrel Bisulfate	92	33
Atenolol	Atenolol	89	28
Metformin Hcl	Metformin Hcl	87	32
Metoprolol Tartrate	Metoprolol Tartrate	87	37
Lorazepam	Lorazepam	86	31
Montelukast Sodium	Montelukast Sodium	86	24
Alprazolam	Alprazolam	85	22
Tamsulosin Hcl	Tamsulosin Hcl	78	28
Citalopram Hbr	Citalopram Hydrobromide	77	28
Fluticasone Propionate	Fluticasone Propionate	77	28
Gabapentin	Gabapentin	77	28
Metformin Hcl Er	Metformin Hcl	77	27
Valsartan	Valsartan	77	27
Sertraline Hcl	Sertraline Hcl	75	26
Carvedilol	Carvedilol	73	30
Duloxetine Hcl	Duloxetine Hcl	73	28
Fluoxetine Hcl	Fluoxetine Hcl	69	28
Allopurinol	Allopurinol	67	29
Hydralazine Hcl	Hydralazine Hcl	60	24
Spironolactone	Spironolactone	58	23
Ezetimibe	Ezetimibe	55	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	29
Meloxicam	Meloxicam	55	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	16
Jardiance	Empagliflozin	50	12
Alendronate Sodium	Alendronate Sodium	49	18
Clonazepam	Clonazepam	48	11
Propranolol Hcl	Propranolol Hcl	47	15
Simvastatin	Simvastatin	47	19
Warfarin Sodium	Warfarin Sodium	47	25
Tramadol Hcl	Tramadol Hcl	46	15
Glipizide	Glipizide	45	15
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	44	suppressed
Buspirone Hcl	Buspirone Hcl	43	15
Synthroid	Levothyroxine Sodium	43	16
Memantine Hcl	Memantine Hcl	41	12
Trazodone Hcl	Trazodone Hcl	41	19
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	40	suppressed
Ondansetron Hcl	Ondansetron Hcl	40	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	14
Esomeprazole Magnesium	Esomeprazole Magnesium	38	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	16
Valacyclovir	Valacyclovir Hcl	38	15
Celecoxib	Celecoxib	37	11
Glimepiride	Glimepiride	37	15
Ozempic	Semaglutide	36	suppressed
Darunavir	Darunavir	33	suppressed
Indapamide	Indapamide	33	12
Ritonavir	Ritonavir	33	suppressed
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Meclizine Hcl	Meclizine Hcl	29	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	11
Pregabalin	Pregabalin	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Prednisone	Prednisone	27	15
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	13
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	11
Temazepam	Temazepam	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Colestipol Hcl	Colestipol Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Isentress	Raltegravir Potassium	18	suppressed
Nadolol	Nadolol	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Tivicay	Dolutegravir Sodium	17	suppressed
Fluconazole	Fluconazole	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Estradiol	Estradiol	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Diazepam	Diazepam	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Vemlidy	Tenofovir Alafenamide	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Klor-Con M20	Potassium Chloride	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Metolazone	Metolazone	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Primidone	Primidone	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Tirosint	Levothyroxine Sodium	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error